These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30335414)

  • 1. Worse cognitive performance predicts increased anxiety and depressive symptoms in patients with Parkinson's disease: A bidirectional analysis.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Petzinger G
    Neuropsychology; 2019 Jan; 33(1):35-46. PubMed ID: 30335414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.
    Jones JD; Kurniadi NE; Kuhn TP; Szymkowicz SM; Bunch J; Rahmani E
    Neuropsychology; 2019 Nov; 33(8):1111-1120. PubMed ID: 31343240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson's disease.
    Timblin H; Rahmani E; Ryczek CA; Hill CR; Jones JD
    Neuropsychology; 2022 Sep; 36(6):505-512. PubMed ID: 35737532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease.
    Park JH; Lee SH; Kim Y; Park SW; Byeon GH; Jang JW;
    Psychogeriatrics; 2020 Nov; 20(6):880-890. PubMed ID: 32840032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson's disease.
    Schroeders U; Zimmermann J; Wicke T; Schaumburg M; Lang E; Trenkwalder C; Mollenhauer B
    Neuropsychology; 2022 May; 36(4):266-278. PubMed ID: 35175065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
    Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses.
    Szymkowicz SM; Jones JD; Timblin H; Ryczek CA; Taylor WD; May PE
    Am J Geriatr Psychiatry; 2022 Jun; 30(6):664-674. PubMed ID: 34922823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms.
    Meng D; Jin Z; Wang Y; Fang B
    CNS Neurosci Ther; 2023 Aug; 29(8):2259-2266. PubMed ID: 36924300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
    Lee PC; Artaud F; Cormier-Dequaire F; Rascol O; Durif F; Derkinderen P; Marques AR; Bourdain F; Brandel JP; Pico F; Lacomblez L; Bonnet C; Brefel-Courbon C; Ory-Magne F; Grabli D; Klebe S; Mangone G; You H; Mesnage V; Brice A; Vidailhet M; Corvol JC; Elbaz A;
    Mov Disord; 2019 Nov; 34(11):1663-1671. PubMed ID: 31518456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contributions of depression, apathy, and anxiety to neuropsychological performance in Parkinson's disease versus essential tremor.
    Ratajska AM; Scott BM; Lopez FV; Kenney LE; Foote KD; Okun MS; Price C; Bowers D
    J Clin Exp Neuropsychol; 2022 Nov; 44(9):651-664. PubMed ID: 36600515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal dynamics of cognitive performance and anxiety across older adulthood.
    Petkus AJ; Reynolds CA; Wetherell JL; Kremen WS; Gatz M
    Psychol Aging; 2017 May; 32(3):278-292. PubMed ID: 28333502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive phenotypes in Parkinson's disease: A latent profile analysis.
    Barvas E; Mattavelli G; Zappini F; Giardina F; Ottaviani D; Papagno C
    Neuropsychology; 2021 May; 35(4):451-459. PubMed ID: 34043394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
    Jones JD; Burroughs M; Apodaca M; Bunch J
    Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study.
    Pirogovsky-Turk E; Moore RC; Filoteo JV; Litvan I; Song DD; Lessig SL; Schiehser DM
    Am J Geriatr Psychiatry; 2017 Mar; 25(3):279-289. PubMed ID: 27838315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for depression and anxiety in Parkinson's disease.
    Yang S; Sajatovic M; Walter BL
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):113-21. PubMed ID: 22689704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported physical activity levels and clinical progression in early Parkinson's disease.
    Amara AW; Chahine L; Seedorff N; Caspell-Garcia CJ; Coffey C; Simuni T;
    Parkinsonism Relat Disord; 2019 Apr; 61():118-125. PubMed ID: 30554993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood Differences Among Parkinson's Disease Patients With Mild Cognitive Impairment.
    Jones JD; Mangal P; Lafo J; Okun MS; Bowers D
    J Neuropsychiatry Clin Neurosci; 2016; 28(3):211-6. PubMed ID: 26792098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered BDNF levels are associated with cognitive impairment in Parkinson's disease patients with depression.
    Wang Y; Bai LP; Liu W; Zhu XD; Zhang XY
    Parkinsonism Relat Disord; 2022 Oct; 103():122-128. PubMed ID: 36108429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.